nitidine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
nitidine: RN given refers to parent cpd; synonym NSC 146397 refers to chloride; structure
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, N | 1 |
| Li, P | 1 |
| Zang, S | 1 |
| Liu, Q | 1 |
| Ma, D | 1 |
| Sun, X | 1 |
| Ji, C | 1 |
1 other study available for nitidine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.
Topics: Antineoplastic Agents; Apoptosis; Benzophenanthridines; Cell Differentiation; Down-Regulation; Drug | 2015 |